Literature DB >> 3048632

Osteosarcoma of the uterine cervix associated with hyperplastic and atypical mesonephric rests.

T Bloch1, L M Roth, F B Stehman, M T Hull, G R Schwenk.   

Abstract

The authors describe a unique case of osteosarcoma associated with atypical mesonephric rests occurring in the right lateral wall of the uterine cervix. The tumor was examined histologically, cytologically, immunohistochemically, and ultrastructurally and was compared with another osteosarcoma that filled an entire uterine cavity. Comparison with other neoplasms of the uterine cervix indicates that the lesion should be classified separately. Previously reported neoplasms associated with mesonephric rests within the cervix are also reviewed.

Entities:  

Mesh:

Year:  1988        PMID: 3048632     DOI: 10.1002/1097-0142(19881015)62:8<1594::aid-cncr2820620823>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Carcinosarcoma of the uterine cervix: a rare pathological finding originating from mesonephric remnants.

Authors:  Bárbara Ribeiro; Raquel Silva; Renata Dias; Vanda Patrício
Journal:  BMJ Case Rep       Date:  2019-03-31

Review 2.  Endobronchial metastasis from a primary uterine osteosarcoma in a patient with multiple myeloma: report of a case.

Authors:  T Akiba; H Ujiie; N Takasaki; T Ohki; H Kurihara; Y Endo; K Sakurai
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

Review 3.  Tumor rupture as an initial manifestation of malignant mesonephric mixed tumor: a case report and review of the literature.

Authors:  Chih-En Tseng; Chien-Han Chen; Shao-Jer Chen; Chen-Lin Chi
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

Review 4.  Mesonephric adenocarcinoma with a sarcomatous component, a notable subtype of cervical carcinosarcoma: a case report and review of the literature.

Authors:  Shiori Meguro; Masanori Yasuda; Michio Shimizu; Akira Kurosaki; Keiichi Fujiwara
Journal:  Diagn Pathol       Date:  2013-05-07       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.